Jeany Cheng
Hematology & Oncology · Arcadia, CANPI 1205855772
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.6% of the total across 286 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations.
Across 286 payments — averaging $33.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$2K
- Incyte Corporation$1K
- Sanofi$1K
- Novartis$882
- Pfizer$664
- Dermavant Sciences, Inc.$565
- plus $4K from 16 others
What the payments were for
- Travel & lodging$70%
- Food & beverage$9,17696%
- Education$4144%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 36 | $1,560 |
| Incyte Corporation | 52 | $1,135 |
| Sanofi | 33 | $1,114 |
| Novartis | 33 | $882 |
| Pfizer | 16 | $664 |
| Dermavant Sciences, Inc. | 8 | $565 |
| UCB, Inc. | 10 | $504 |
| LEO Pharma Inc. | 23 | $482 |
| Johnson & Johnson | 11 | $397 |
| AbbVie | 12 | $391 |
| Galderma Laboratories, L.p. | 7 | $380 |
| Lilly USA, LLC | 8 | $285 |
| Amgen | 9 | $253 |
| Botanix SB Inc | 3 | $237 |
| Arcutis Biotherapeutics, Inc. | 9 | $234 |
| Organon | 4 | $216 |
| E.r. Squibb & Sons, L.L.C. | 3 | $111 |
| Sun Pharmaceutical Industries Inc. | 4 | $68 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $46 |
| Almirall LLC | 1 | $30 |
| Regeneron | 1 | $26 |
| Phadia US Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,598 in reported general payments places this provider in the 65th percentile of 1,363 hematology & oncology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 14 | $631 |
| Clobetasol Propionate | 26 | $592 |
| Ketoconazole | 31 | $452 |
| Doxycycline Hyclate | 21 | $251 |
| Mometasone Furoate | 13 | $232 |
| Mupirocin | 18 | $100 |
| Triamcinolone Acetonide | 13 | $75 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Arcadia
- Dennis SlamonLos Angeles$3.1M
- Sandra HorningStanford$2.5M
- Mohammadbagher ZiariCorona$2.5M
- George YaghmourLos Angeles$1.9M
- Robert VescioWest Hollywood$1.1M
- Kevin KellyLos Angeles$894K
- Johnny ChangEncino$884K
- Nitin RohatgiSacramento$814K
- Omid HamidSanta Monica$809K
- Catherine CoombsOrange$786K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.